To date, some agents, for example, some Bifidobacterium strains and lactoferrin, have been demonstrated to significantly reduce the incidence of NEC and sepsis in preterm infants, but their impact on the premature immune system has not been evaluated [67,68]. The gene discussed is LTF; the disease is necrotizing enterocolitis.